NKTR
Price
$56.56
Change
-$1.44 (-2.48%)
Updated
Oct 8 closing price
Capitalization
1.08B
RXRX
Price
$6.09
Change
+$0.86 (+16.44%)
Updated
Oct 8 closing price
Capitalization
2.66B
27 days until earnings call
Interact to see
Advertisement

NKTR vs RXRX

Header iconNKTR vs RXRX Comparison
Open Charts NKTR vs RXRXBanner chart's image
Nektar Therapeutics
Price$56.56
Change-$1.44 (-2.48%)
Volume$1.01M
Capitalization1.08B
Recursion Pharmaceuticals
Price$6.09
Change+$0.86 (+16.44%)
Volume$94.2M
Capitalization2.66B
NKTR vs RXRX Comparison Chart in %
NKTR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NKTR vs. RXRX commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NKTR is a StrongBuy and RXRX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 09, 2025
Stock price -- (NKTR: $56.56 vs. RXRX: $6.09)
Brand notoriety: NKTR: Notable vs. RXRX: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NKTR: 98% vs. RXRX: 362%
Market capitalization -- NKTR: $1.08B vs. RXRX: $2.66B
NKTR [@Biotechnology] is valued at $1.08B. RXRX’s [@Biotechnology] market capitalization is $2.66B. The market cap for tickers in the [@Biotechnology] industry ranges from $107.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.07B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NKTR’s FA Score shows that 0 FA rating(s) are green whileRXRX’s FA Score has 1 green FA rating(s).

  • NKTR’s FA Score: 0 green, 5 red.
  • RXRX’s FA Score: 1 green, 4 red.
According to our system of comparison, RXRX is a better buy in the long-term than NKTR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NKTR’s TA Score shows that 2 TA indicator(s) are bullish while RXRX’s TA Score has 6 bullish TA indicator(s).

  • NKTR’s TA Score: 2 bullish, 6 bearish.
  • RXRX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, RXRX is a better buy in the short-term than NKTR.

Price Growth

NKTR (@Biotechnology) experienced а -3.89% price change this week, while RXRX (@Biotechnology) price change was +19.41% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.02%. For the same industry, the average monthly price growth was +18.92%, and the average quarterly price growth was +86.47%.

Reported Earning Dates

RXRX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+9.02% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RXRX($2.66B) has a higher market cap than NKTR($1.08B). NKTR YTD gains are higher at: 305.448 vs. RXRX (-9.911). NKTR has higher annual earnings (EBITDA): -87.3M vs. RXRX (-583.64M). RXRX has more cash in the bank: 525M vs. NKTR (176M). RXRX has less debt than NKTR: RXRX (88.1M) vs NKTR (96.2M). NKTR has higher revenues than RXRX: NKTR (74.9M) vs RXRX (64.5M).
NKTRRXRXNKTR / RXRX
Capitalization1.08B2.66B40%
EBITDA-87.3M-583.64M15%
Gain YTD305.448-9.911-3,082%
P/E RatioN/AN/A-
Revenue74.9M64.5M116%
Total Cash176M525M34%
Total Debt96.2M88.1M109%
FUNDAMENTALS RATINGS
NKTR: Fundamental Ratings
NKTR
OUTLOOK RATING
1..100
19
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
84
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NKTRRXRX
RSI
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
88%
Momentum
ODDS (%)
Bearish Trend 1 day ago
81%
Bullish Trend 1 day ago
85%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
87%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 7 days ago
78%
Bullish Trend 8 days ago
84%
Declines
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 25 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 1 day ago
86%
Aroon
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
NKTR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AEDYX36.69N/A
N/A
Invesco International Value Y
TILIX78.77N/A
N/A
Nuveen Large Cap Gr Idx R6
GIUIX38.39N/A
N/A
NAA Mid Growth Institutional
BRUNX17.25N/A
N/A
MFS Blended Research Value Equity R6
GGKPX27.60N/A
N/A
Goldman Sachs Income Builder P

NKTR and

Correlation & Price change

A.I.dvisor indicates that over the last year, NKTR has been loosely correlated with SLS. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if NKTR jumps, then SLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NKTR
1D Price
Change %
NKTR100%
-2.48%
SLS - NKTR
42%
Loosely correlated
+1.58%
AMLX - NKTR
38%
Loosely correlated
-0.07%
SKYE - NKTR
37%
Loosely correlated
+3.61%
EYPT - NKTR
36%
Loosely correlated
+4.75%
RXRX - NKTR
36%
Loosely correlated
+16.44%
More